Newave Pharmaceutical Inc.

Organization

Pleasanton, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
BCL-2 inhibitors
- Patent number 12,220,419
- Issue date Feb 11, 2025
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazines as inhibitors of BTK, and mutants thereof
- Patent number 12,086,788
- Issue date Sep 10, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
BCL-2 inhibitors
- Patent number 11,993,610
- Issue date May 28, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BCL-2 inhibitors
- Patent number 11,903,950
- Issue date Feb 20, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Condensed heterocyclic derivates as BCL-2 inhibitors for the treatm...
- Patent number 11,680,072
- Issue date Jun 20, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazines as inhibitors of BTK, and mutants thereof
- Patent number 11,501,284
- Issue date Nov 15, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones as inhib...
- Patent number 11,479,555
- Issue date Oct 25, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BCL-2 inhibitors
- Patent number 11,365,206
- Issue date Jun 21, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Condensed heterocyclic derivates as BCL-2 inhibitors for the treatm...
- Patent number 11,279,711
- Issue date Mar 22, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic agents for the treatment of HBV infection
- Patent number 10,501,456
- Issue date Dec 10, 2019
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent inhibitors of CDK-7
- Patent number 10,456,397
- Issue date Oct 29, 2019
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCL-2 inhibitors
- Patent number 10,377,755
- Issue date Aug 13, 2019
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-warhead covalent inhibitors of FGFR-4
- Patent number 10,253,029
- Issue date Apr 9, 2019
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic agents for the treatment of HBV infection
- Patent number 10,239,872
- Issue date Mar 26, 2019
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Covalent inhibitors of CDK-7
- Patent number 10,195,200
- Issue date Feb 5, 2019
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
BCL-2 INHIBITORS
- Publication number 20250051329
- Publication date Feb 13, 2025
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF BTK AND MUTANTS THEREOF
- Publication number 20250045728
- Publication date Feb 6, 2025
- Newave Pharmaceutical Inc.
- Yi Chen
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20240425520
- Publication date Dec 26, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITOR OF BTK AND MUTANTS THEREOF
- Publication number 20240390368
- Publication date Nov 28, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS
- Publication number 20240217964
- Publication date Jul 4, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20240180924
- Publication date Jun 6, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE T...
- Publication number 20240166646
- Publication date May 23, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BTK DEGRADER
- Publication number 20240058457
- Publication date Feb 22, 2024
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF BTK
- Publication number 20230382900
- Publication date Nov 30, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BTK AND MUTANTS...
- Publication number 20230346779
- Publication date Nov 2, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR
- Publication number 20230295183
- Publication date Sep 21, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATM...
- Publication number 20230271979
- Publication date Aug 31, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF BTK AND MUTANTS THEREOF
- Publication number 20230140433
- Publication date May 4, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE T...
- Publication number 20230119463
- Publication date Apr 20, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS
- Publication number 20230089530
- Publication date Mar 23, 2023
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20220402941
- Publication date Dec 22, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDENSED HETEROCYCLES AS BCL-2 INHIBITORS
- Publication number 20220372042
- Publication date Nov 24, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITOR OF BTK AND MUTANTS THEREOF
- Publication number 20220363689
- Publication date Nov 17, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATM...
- Publication number 20220220126
- Publication date Jul 14, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITOR OF BTK AND MUTANTS THEREOF
- Publication number 20220135569
- Publication date May 5, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS BCL-...
- Publication number 20220073513
- Publication date Mar 10, 2022
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20210332065
- Publication date Oct 28, 2021
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20210315904
- Publication date Oct 14, 2021
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20210171523
- Publication date Jun 10, 2021
- Newave Pharmaceutical Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDINE-3-ONE COMPOUNDS AS INHIBIT...
- Publication number 20210061807
- Publication date Mar 4, 2021
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF BTK AND MUTANTS THEREOF
- Publication number 20200377478
- Publication date Dec 3, 2020
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COVALENT INHIBITORS OF CDK-7
- Publication number 20200297724
- Publication date Sep 24, 2020
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF HBV INFECTION
- Publication number 20200223841
- Publication date Jul 16, 2020
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCL-2 INHIBITORS
- Publication number 20200197406
- Publication date Jun 25, 2020
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATM...
- Publication number 20200190109
- Publication date Jun 18, 2020
- Newave Pharmaceutical Inc.
- Yi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Newave Pharmaceutical Inc.

Organization

Patents Grantslast 30 patents

BCL-2 inhibitors

Substituted pyrazines as inhibitors of BTK, and mutants thereof

BCL-2 inhibitors

BCL-2 inhibitors

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatm...

Substituted pyrazines as inhibitors of BTK, and mutants thereof

Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones as inhib...

BCL-2 inhibitors

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatm...

Therapeutic agents for the treatment of HBV infection

Covalent inhibitors of CDK-7

BCL-2 inhibitors

Dual-warhead covalent inhibitors of FGFR-4

Therapeutic agents for the treatment of HBV infection

Covalent inhibitors of CDK-7

Patents Applicationslast 30 patents

BCL-2 INHIBITORS

INHIBITORS OF BTK AND MUTANTS THEREOF

BCL-2 INHIBITORS

INHIBITOR OF BTK AND MUTANTS THEREOF

QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS

BCL-2 INHIBITORS

1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE T...

BTK DEGRADER

INHIBITORS OF BTK

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BTK AND MUTANTS...

HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR

CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATM...

INHIBITORS OF BTK AND MUTANTS THEREOF

1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE T...

QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS

BCL-2 INHIBITORS

CONDENSED HETEROCYCLES AS BCL-2 INHIBITORS

INHIBITOR OF BTK AND MUTANTS THEREOF

CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATM...

INHIBITOR OF BTK AND MUTANTS THEREOF

1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS BCL-...

BCL-2 INHIBITORS

BCL-2 INHIBITORS

BCL-2 INHIBITORS

1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDINE-3-ONE COMPOUNDS AS INHIBIT...

INHIBITORS OF BTK AND MUTANTS THEREOF

COVALENT INHIBITORS OF CDK-7

NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF HBV INFECTION

BCL-2 INHIBITORS

CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATM...